Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - JOUR LB - 1. AU - Duffy, MJ AU - Lamerz, R AU - Haglund, C AU - Nicolini, A AU - Kalousová, M AU - Holubec, L AU - Sturgeon, C TI - Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update J2 - Int J Cancer PY - 2014 VL - 134 SP - 2513 EP - 2522 UR - http://dx.doi.org/10.1002/ijc.28384 ER - TY - JOUR LB - 2. AU - Labianca, R AU - Nordlinger, B AU - Beretta, GD AU - Brouquet, A AU - Cervantes, A AU - ESMO Guidelines Working Group TI - Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up J2 - Ann Oncol PY - 2010 VL - 21 IS - Suppl. 5 SP - 70 EP - 77 UR - http://dx.doi.org/10.1093/annonc/mdq168 ER - TY - JOUR LB - 3. AU - Locker, GY AU - Hamilton, S AU - Harris, J AU - Jessup, JM AU - Kemeny, N AU - Macdonald, JS TI - ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer J2 - J Clin Oncol PY - 2006 VL - 24 SP - 5313 EP - 5327 UR - http://dx.doi.org/10.1200/JCO.2006.08.2644 ER - TY - BOOK LB - 4. AU - Freedman-Cass, D AU - Gregory, KM TI - Clinical Practice Guidelines in Oncology (NCCN Guidelines): Colon Cancer CY - Fort Washington, PA PB - National Comprehensive Cancer Network Foundation PY - 2016 ER - TY - ELEC LB - 5. AU - National Institute for Health and Care Excellence TI - Colorectal Cancer: Diagnosis and Management UR - www.nice.org.uk/guidance/cg131/chapter/1-recommendations 2011 M1 - 5 December 2015 ER - TY - JOUR LB - 6. AU - Sturgeon, CM AU - Lai, LC AU - Duffy, MJ TI - Serum tumour markers: how to order and interpret them J2 - BMJ PY - 2009 VL - 339 SP - b3527 UR - http://dx.doi.org/10.1136/bmj.b3527 ER - TY - JOUR LB - 7. AU - Newton, KF AU - Newman, W AU - Hill, J TI - Review of biomarkers in colorectal cancer J2 - Colorectal Dis PY - 2012 VL - 14 SP - 3 EP - 17 UR - http://dx.doi.org/10.1111/j.1463-1318.2010.02439.x ER - TY - JOUR LB - 8. AU - Goldstein, MJ AU - Mitchell, EP TI - Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer J2 - Cancer Invest PY - 2005 VL - 23 SP - 338 EP - 351 UR - http://dx.doi.org/10.1081/CNV-58878 ER - TY - JOUR LB - 9. AU - Scheer, A AU - Auer, RA TI - Surveillance after curative resection of colorectal cancer J2 - Clin Colon Rectal Surg PY - 2009 VL - 22 SP - 242 EP - 250 UR - http://dx.doi.org/10.1055/s-0029-1242464 ER - TY - JOUR LB - 10. AU - Tsikitis, VL AU - Malireddy, K AU - Green, EA AU - Christensen, B AU - Whelan, R AU - Hyder, J TI - Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial J2 - J Clin Oncol PY - 2009 VL - 27 SP - 3671 EP - 3676 UR - http://dx.doi.org/10.1200/JCO.2008.20.7050 ER - TY - JOUR LB - 11. AU - Jeffery, M AU - Hickey, BE AU - Hilder, PN TI - Follow-up strategies for patients treated for non-metastatic colorectal cancer J2 - Cochrane Database Syst Rev PY - 2007 VL - 1 SP - CD002200 UR - http://dx.doi.org/10.1002/14651858.cd002200.pub2 ER - TY - JOUR LB - 12. AU - Primrose, JN AU - Perera, R AU - Gray, A AU - Rose, P AU - Fuller, A AU - Corkhill, A TI - Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial J2 - JAMA PY - 2014 VL - 311 SP - 263 EP - 270 UR - http://dx.doi.org/10.1001/jama.2013.285718 ER - TY - JOUR LB - 13. AU - Tan, E AU - Gouvas, N AU - Nicholls, RJ AU - Ziprin, P AU - Xynos, E AU - Tekkis, PP TI - Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer J2 - Surg Oncol PY - 2009 VL - 18 SP - 15 EP - 24 UR - http://dx.doi.org/10.1016/j.suronc.2008.05.008 ER - TY - JOUR LB - 14. AU - Glasziou, P AU - Irwig, L AU - Mant, D TI - Monitoring in chronic disease: a rational approach J2 - BMJ PY - 2005 VL - 330 SP - 644 EP - 648 UR - http://dx.doi.org/10.1136/bmj.330.7492.644 ER - TY - GEN LB - 15. TI - Cochrane Diagnostic Review Group Quality Criteria UR - http://methods.cochrane.org/sdt/handbook-dta-reviews Y2 - 5 November 2016 ER - TY - JOUR LB - 16. AU - Nicholson, BD AU - Shinkins, B AU - Pathiraja, I AU - Roberts, NW AU - James, TJ AU - Mallett, S TI - Blood CEA levels for detecting recurrent colorectal cancer J2 - Cochrane Database Syst Rev PY - 2015 VL - 12 SP - CD011134 UR - http://dx.doi.org/10.1002/14651858.CD011134.pub2 ER - TY - JOUR LB - 17. AU - Shinkins, B AU - Nicholson, BD AU - Primrose, J AU - Perera, R AU - James, T AU - Pugh, S TI - The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: results from the FACS trial J2 - PLOS ONE PY - 2017 VL - 12 SP - e0171810 ER - TY - JOUR LB - 18. AU - Whiting, PF AU - Rutjes, AW AU - Westwood, ME AU - Mallett, S AU - Deeks, JJ AU - Reitsma, JB TI - QUADAS–2: a revised tool for the quality assessment of diagnostic accuracy studies J2 - Ann Intern Med PY - 2011 VL - 55 SP - 529 EP - 536 UR - http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00009 ER - TY - JOUR LB - 19. AU - Reitsma, JB AU - Glas, AS AU - Rutjes, AW AU - Scholten, RJ AU - Bossuyt, PM AU - Zwinderman, AH TI - Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews J2 - J Clin Epidemiol PY - 2005 VL - 58 SP - 982 EP - 990 UR - http://dx.doi.org/10.1016/j.jclinepi.2005.02.022 ER - TY - ELEC LB - 20. AU - Takwoingi, Y TI - Meta-Analysis of Test Accuracy Studies in Stata: A Bivariate Model Approach. Version 1 UR - http://methods.cochrane.org/sites/methods.cochrane.org.sdt/files/public/uploads/Chapter%2010%20-%20Version%201.0.pdf M1 - 6 November 2016 ER - TY - JOUR LB - 21. AU - Sargent, DJ AU - Patiyil, S AU - Yothers, G AU - Haller, DG AU - Gray, R AU - Benedetti, J TI - End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group J2 - J Clin Oncol PY - 2007 VL - 25 SP - 4569 EP - 4574 UR - http://dx.doi.org/10.1200/JCO.2006.10.4323 ER - TY - ELEC LB - 22. AU - Agency for Healthcare Research and Quality TI - National Guideline Clearing House. Follow-Up of Colorectal Cancer or Polyps UR - www.guideline.gov/summaries/summary/46911 M1 - 5 November 2016 ER - TY - JOUR LB - 23. AU - Laurence, DJ AU - Turberville, C AU - Anderson, SG AU - Neville, AM TI - First British standard for carcinoembryonic antigen (CEA) J2 - Br J Cancer PY - 1975 VL - 32 SP - 295 EP - 299 UR - http://dx.doi.org/10.1038/bjc.1975.227 ER - TY - JOUR LB - 24. AU - Moses, LE AU - Shapiro, D AU - Littenberg, B TI - Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations J2 - Stat Med PY - 1993 VL - 12 SP - 1293 EP - 1316 UR - http://dx.doi.org/10.1002/sim.4780121403 ER - TY - GEN LB - 25. AU - Cochrane TI - Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy UR - http://methods.cochrane.org/sdt/handbook-dta-reviews Y2 - 5 November 2016 ER - TY - JOUR LB - 26. AU - Robin, X AU - Turck, N AU - Hainard, A AU - Tiberti, N AU - Lisacek, F AU - Sanchez, JC AU - Müller, M TI - pROC: an open-source package for R and S+ to analyze and compare ROC curves J2 - BMC Bioinformatics PY - 2011 VL - 12 SP - 77 UR - http://dx.doi.org/10.1186/1471-2105-12-77 ER - TY - JOUR LB - 27. AU - Shinkins, B AU - Nicholson, BD AU - James, TJ AU - Primrose, JN AU - Mant, D TI - Carcinoembryonic antigen monitoring to detect recurrence of colorectal cancer: how should we interpret the test results? J2 - Clin Chem PY - 2014 VL - 60 SP - 1572 EP - 1574 UR - http://dx.doi.org/10.1373/clinchem.2014.228601 ER - TY - JOUR LB - 28. AU - Su, BB AU - Shi, H AU - Wan, J TI - Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection J2 - World J Gastroenterol PY - 2012 VL - 18 SP - 2121 EP - 2126 UR - http://dx.doi.org/10.3748/wjg.v18.i17.2121 ER - TY - JOUR LB - 29. AU - André, T AU - Boni, C AU - Navarro, M AU - Tabernero, J AU - Hickish, T AU - Topham, C TI - Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J2 - J Clin Oncol PY - 2009 VL - 27 SP - 3109 EP - 3116 UR - http://dx.doi.org/10.1200/JCO.2008.20.6771 ER - TY - JOUR LB - 30. AU - Minton, JP AU - Martin, EW TI - The use of serial CEA determinations to predict recurrence of colon cancer and when to do a second-look operation J2 - Cancer PY - 1978 VL - 42 IS - Suppl. 3 SP - 1422 EP - 1427 UR - http://dx.doi.org/10.1002/1097-0142(197809)42:3+<1422::AID-CNCR2820420807>3.0.CO;2-1 ER - TY - JOUR LB - 31. AU - Staab, HJ AU - Anderer, FA AU - Stumpf, E AU - Hornung, A AU - Fischer, R AU - Kieninger, G TI - Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer J2 - Am J Surg PY - 1985 VL - 149 SP - 198 EP - 204 UR - http://dx.doi.org/10.1016/S0002-9610(85)80064-7 ER - TY - JOUR LB - 32. AU - Carl, J AU - Bentzen, SM AU - Nørgaard-Pedersen, B AU - Kronborg, O TI - Modelling of serial carcinoembryonic antigen changes in colorectal cancer J2 - Scand J Clin Lab Invest PY - 1993 VL - 53 SP - 751 EP - 755 UR - http://dx.doi.org/10.3109/00365519309092581 ER - TY - JOUR LB - 33. AU - Boey, J AU - Cheung, HC AU - Lai, CK AU - Wong, J TI - A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma J2 - World J Surg PY - 1984 VL - 8 SP - 279 EP - 286 UR - http://dx.doi.org/10.1007/BF01655052 ER - TY - JOUR LB - 34. AU - Verberne, CJ AU - Zhan, Z AU - van den Heuvel, E AU - Grossmann, I AU - Doornbos, PM AU - Havenga, K TI - Intensified follow-up in colorectal cancer patients using frequent carcino-embryonic antigen (CEA) measurements and CEA-triggered imaging: results of the randomised ‘CEAwatch’ trial J2 - Eur J Surg Oncol PY - 2015 VL - 41 SP - 1188 EP - 1196 UR - http://dx.doi.org/10.1016/j.ejso.2015.06.008 ER - TY - JOUR LB - 35. AU - Grossmann, I AU - Verberne, C AU - De Bock, G AU - Havenga, K AU - Kema, I AU - Klaase, J TI - The role of High frequency Dynamic Threshold (HiDT) Serum Carcinoembryonic antigen (CEA) measurements in colorectal cancer surveillance: a (revisited) hypothesis paper J2 - Cancers PY - 2011 VL - 3 SP - 2302 EP - 2315 UR - http://dx.doi.org/10.3390/cancers3022302 ER - TY - JOUR LB - 36. AU - Huang, YY AU - Lee, PI AU - Liu, MC AU - Chen, CC AU - Huang, KC AU - Huang, AT TI - A general cutoff level combined with personalised dynamic change of serum carcinoembryonic antigen can suggest timely use of FDG PET for early detection of recurrent colorectal cancer J2 - Clin Nucl Med PY - 2015 VL - 40 SP - e465 EP - e469 UR - http://dx.doi.org/10.1097/RLU.0000000000000900 ER - TY - JOUR LB - 37. AU - Ito, K AU - Hibi, K AU - Ando, H AU - Hidemura, K AU - Yamazaki, T AU - Akiyama, S AU - Nakao, A TI - Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma J2 - Jpn J Clin Oncol PY - 2002 VL - 32 SP - 54 EP - 58 UR - http://dx.doi.org/10.1093/jjco/hyf011 ER - TY - JOUR LB - 38. AU - Litvak, A AU - Cercek, A AU - Segal, N AU - Reidy-Lagunes, D AU - Stadler, ZK AU - Yaeger, RD TI - False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer J2 - J Natl Compr Canc Netw PY - 2014 VL - 12 SP - 907 EP - 913 ER - TY - ELEC LB - 39. AU - International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use TI - ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice E6(R1) PY - 1996 UR - www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf M1 - 6 November 2016 ER - TY - ELEC LB - 40. AU - European Parliament and Council TI - Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the Approximation of the Laws, Regulations and Administrative Provisions of the Member States Relating to the Implementation of Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use UR - http://ec.europa.eu/health/files/eudralex/vol-1/dir_2001_20/dir_2001_20_en.pdf M1 - 6 November 2016 ER - TY - GEN LB - 41. TI - NHS NIHR Research Governance Framework UR - www.nihr.ac.uk/policy-and-standards/framework-for-research-support-services.htm Y2 - 6 November 2016 ER -